Key facts
- This page summarizes Thomas C. Reynolds's Form 4 filing for MEI Pharma, Inc. (MEIP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jul 2025, 21:39.
Thomas C. Reynolds - 15 Jul 2025 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)
- Reporting relationship
- Director
- Issuer ticker
- MEIP
- Reported as of
- 15 Jul 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jul 2025, 21:39:19 UTC
- Prior SEC filing
- 12 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas C. Reynolds
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas C. Reynolds filed Form 4 for MEI Pharma, Inc. (MEIP) on 17 Jul 2025.
Change
- Previous filing in this sequence was filed on 12 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001393945
Primary reporting owner
Reynolds Thomas C
- Relationship
- Director
- Address
- C/O MEI PHARMA, INC., 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO
- Signature
- /s/ Thomas C. Reynolds
- Signature date
- 17 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEIP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 15 Jul 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MEIP
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 15 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $3.07
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.